PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19585164-5	2009	Data demonstrates that gene expression levels of PPARalpha and apolipoprotein AI (APOA1) were significantly lower for carriers of the PPARalpha-V162 allele compared to L162 homozygotes after the addition of DHA and a mixture of EPA:DHA.	Docosahexaenoic Acids	207-210	peroxisome proliferator activated receptor alpha	Homo sapiens	49-58	
19585164-5	2009	Data demonstrates that gene expression levels of PPARalpha and apolipoprotein AI (APOA1) were significantly lower for carriers of the PPARalpha-V162 allele compared to L162 homozygotes after the addition of DHA and a mixture of EPA:DHA.	Docosahexaenoic Acids	207-210	peroxisome proliferator activated receptor alpha	Homo sapiens	134-143	
19585164-5	2009	Data demonstrates that gene expression levels of PPARalpha and apolipoprotein AI (APOA1) were significantly lower for carriers of the PPARalpha-V162 allele compared to L162 homozygotes after the addition of DHA and a mixture of EPA:DHA.	Docosahexaenoic Acids	232-235	peroxisome proliferator activated receptor alpha	Homo sapiens	49-58	
19585164-5	2009	Data demonstrates that gene expression levels of PPARalpha and apolipoprotein AI (APOA1) were significantly lower for carriers of the PPARalpha-V162 allele compared to L162 homozygotes after the addition of DHA and a mixture of EPA:DHA.	Docosahexaenoic Acids	232-235	peroxisome proliferator activated receptor alpha	Homo sapiens	134-143	
19585164-6	2009	Additionally, lipoprotein lipase (LPL) gene expression displayed a tendency to be lower in the PPARalpha L162V polymorphism subgroup after the addition of a mixture of EPA:DHA.	Docosahexaenoic Acids	172-175	peroxisome proliferator activated receptor alpha	Homo sapiens	95-104